Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.
about
Crystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCPThe traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activationPerturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases.NK cell-based immunotherapy for malignant diseases.The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICBRedirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspectivePalmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding.Regulation of ligands for the NKG2D activating receptor.Recognition of tumors by the innate immune system and natural killer cells.Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells.Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.MHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell linesSoluble ligands for the NKG2D receptor are released during endometriosis and correlate with disease severity.Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Prevalence of the NKG2D Thr72Ala polymorphism in patients with cervical carcinoma.SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathiesAntitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.Regulation of ligands for the activating receptor NKG2D.Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48.Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses.Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cellsTumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.NKG2D ligands in tumor immunity.Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.Effect of NKG2D ligand expression on host immune responsesSoluble MHC I and soluble MIC molecules: potential therapeutic targets for cancer.Role of stress-induced NKG2D ligands in liver diseases.NK cells: key to success of DC-based cancer vaccines?Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.Regulation of self-ligands for activating natural killer cell receptors.Advances in NKG2D ligand recognition and responses by NK cells.Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretionCytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
P2860
Q27674864-C4A93AD3-D4B8-4550-9546-E5F8BD0FC987Q30488939-41AB3045-F97A-4C4F-AC1A-602A0AD53B68Q30547087-AC1488E6-8783-4985-AEF8-80709915BF49Q30648415-55366B96-19C0-416E-9DEA-C32073565FAEQ33555680-F14C3C03-DA87-4A06-9202-9273E058F42CQ33827433-0E33DAE8-C698-4102-BE7C-FAD2D51313B6Q34079158-56AB3D42-3C08-4B99-8A83-5969CE4CD5CDQ34166288-E8353E65-9737-46CC-8109-64D4E4A759F7Q34180695-37D2F2EA-403D-421B-AE1F-ADE51BBB97ECQ34217314-70E9F028-B62A-431E-856A-B6053DB6304AQ34321457-C4D9EEE3-C7B0-4496-8124-936A7BF38E78Q34496462-47A958CE-3366-4F10-BED6-483B02113C68Q34855104-3A16DAFA-D700-41C7-B710-DEA31C6D41BAQ35053561-B46332F3-C159-4D10-B4FE-7F389F3095B3Q35061364-ABF41093-0403-4613-A96C-C37CD58F4E6CQ35181683-555934D3-9F9F-4F9E-B41A-0C3205732796Q35799094-B16AF62C-F154-4D81-9D9D-635CA4C2BBFCQ36174293-6C6C0EDF-FCE6-4FD8-B73A-23C63F48A1F6Q36329547-882481EC-1305-4014-ADF9-221B2C94294FQ36685376-1ADDC9AE-8CB1-4320-BCFB-72E1C670533BQ36868340-F62537BE-D384-46F2-AA3C-FD5B512FC460Q36872056-59EC2B27-1E5D-4398-9D78-F811C7584511Q36942362-67ECF45F-8940-4D13-B92E-5922548E95A1Q37063492-273D9DB2-3934-41D6-BE70-BC9498F625A2Q37128253-FF4E5611-FCA8-4B19-B0AE-3FB03590D40EQ37128257-01D28F27-BCFE-494C-9A2E-B7C65C347473Q37234615-2E2FF9F5-F534-47C9-A7B6-02A4220E70F1Q37242917-CF696FDE-713A-4A94-B401-81FA1381D74FQ37287179-72BD3A8A-96D9-4DD0-8CE3-75C5C6AB520DQ37698501-EE8DBD54-CAA1-403B-9565-8D6078F28A1CQ37721591-4D194B7C-1C01-4004-8B0C-B6FA10AEAFE2Q37764003-F7475E25-F8DC-4234-A2DC-8E7930854AB2Q37828518-006AEFEB-52DC-4840-9A4A-F321D1F6B881Q37957971-A26C0758-83CE-4245-BB66-8E210D73ED8DQ38036202-BC3F68D2-5FE9-4E82-8A3D-BBDEB702A8D4Q38107250-2B136192-44AF-444E-BA4E-0F9EE37CC2BEQ38108820-7E492843-8ACB-4408-B9DA-51B7C155FB41Q38180339-91F22BEB-402D-4870-97A2-1C7216EEBE85Q38706890-8F9EF3AC-8D58-4135-A296-674DF6213519Q38740111-F5120C33-CF1B-485C-9F59-6DBC7E40E719
P2860
Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Release of MICB molecules by t ...... CB in sera of cancer patients.
@en
type
label
Release of MICB molecules by t ...... CB in sera of cancer patients.
@en
prefLabel
Release of MICB molecules by t ...... CB in sera of cancer patients.
@en
P1433
P1476
Release of MICB molecules by t ...... CB in sera of cancer patients.
@en
P2093
Dennis Goehlsdorf
Helmut Rainer Salih
P304
P356
10.1016/J.HUMIMM.2006.02.008
P577
2006-03-29T00:00:00Z